VICARIOUS SURGICAL INC-A (RBOT) Stock Analyst Earnings Estimates
NYSE:RBOT - New York Stock Exchange, Inc. - US92561V2088 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A 76.63% | N/A 72.42% | N/A 100.59% | |||||||
| EBITDA YoY % growth | -9.68M | -12.83M -32.54% | -37.9M -195.40% | -78.97M -108.36% | -78.812M 0.20% | -64.448M 18.23% | N/A 19.36% | N/A 3.34% | N/A 18.58% | N/A | N/A | N/A | |
| EBIT YoY % growth | -9.78M | -12.99M -32.82% | -38.22M -194.23% | -80.08M -109.52% | -80.666M -0.73% | -66.555M 17.49% | N/A 3.14% | N/A -7.59% | N/A 16.13% | N/A | N/A | N/A | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -13.50 26.47% | -14.70 -8.89% | -10.85 26.19% | N/A 11.26% | N/A 25.81% | N/A 21.23% | N/A | N/A | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | |
|---|---|---|---|
| EPS Q2Q % growth | -2.45 15.47% | -2.00 15.43% | -1.84 29.19% |
| Revenue Q2Q % growth | |||
| EBITDA Q2Q % growth | -13.107M 19.04% | -13.311M -3.42% | -12.291M 20.07% |
| EBIT Q2Q % growth | -16.252M 8.47% | -16.66M -11.23% | -16.932M -7.53% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -2.23 13.90% | -2.55 | 0.32 | 12.43% |
| Q1 2025 Q2Q % growth | -2.60 13.33% | -2.53 | -0.07 | -2.78% |
| Q4 2024 Q2Q % growth | -2.36 -31.11% | -2.74 | 0.38 | 13.99% |
| Q3 2024 Q2Q % growth | -2.90 3.33% | -2.61 | -0.29 | -11.28% |
| Q2 2024 Q2Q % growth | -2.59 28.06% | -2.83 | 0.24 | 8.50% |
| Q1 2024 Q2Q % growth | -3.00 52.38% | -2.91 | -0.09 | -3.20% |
| Q4 2023 Q2Q % growth | -1.80 33.33% | -3.83 | 2.03 | 52.94% |
| Q3 2023 Q2Q % growth | -3.00 50.00% | -4.36 | 1.36 | 31.20% |
| Q2 2023 Q2Q % growth | -3.60 -1,100.00% | -4.36 | 0.76 | 17.44% |
| Q1 2023 Q2Q % growth | -6.30 -40.00% | -4.13 | -2.17 | -52.51% |
| Q4 2022 Q2Q % growth | -2.70 40.00% | -5.30 | 2.60 | 49.09% |
| Q3 2022 Q2Q % growth | -6.00 -122.22% | -4.74 | -1.26 | -26.50% |
| Q2 2022 Q2Q % growth | -0.30 | -4.44 | 4.14 | 93.24% |
| Q1 2022 Q2Q % growth | -4.50 | -4.01 | -0.49 | -12.09% |
| Q4 2021 Q2Q % growth | -4.50 | -3.19 | -1.31 | -41.06% |
| Q3 2021 Q2Q % growth | -2.70 | -1.84 | -0.86 | -47.06% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -4.76% | 0% | -8.42% |
| Revenue | N/A | N/A | N/A | N/A |